ClinicalTrials.gg
CompletedNCT06733285Updated Oct 19, 2026Results posted

Clinical Study to Investigate the Ability of a Stannous Fluoride Toothpaste to Protect From Dentine Hypersensitivity

An interventional study of Sensodyne Rapid Relief and Colgate Cavity Protection in Dentin Sensitivity, sponsored by HALEON. Completed at 1 site in United Kingdom. Open to participants aged 18 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-19.

Sponsored by HALEON · Not applicable, Interventional, and Treatment

How we know

Updated Oct 19, 2026Results postedStudy documents posted+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
85
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-20

Among 21 studies in Dentin Sensitivity by HALEON — 3 open to participants now, 3 under way, none of them phase 3. Dentin Sensitivity · HALEON.

Enrollment
19th of 20
85 · median 185
Started
2025
with 3 others
No phase
18 of 21
2 open now
Registered
11th of 21
by date

Among the 21 studies in Dentin Sensitivity by HALEON, this one is the 19th largest by enrollment of the 20 interventional ones that give a count, is one of 4 that started in 2025, is one of 18 with no phase, and was the 11th registered.

Dentin Sensitivity

292 studies on the registry are indexed under Dentin Sensitivity; 49 are open to participants now.

Browse Dentin Sensitivity studies →

Open to participants now

3 of the 21 studies in Dentin Sensitivity by HALEON are open now, in 3 countries. Recruiting first, the newest first:

By country, each count listing its studies:

All 3 open studies →

Who these studies take

Of the 20 Dentin Sensitivity studies recruiting now, 6 (30%) set no upper age limit and 13 (65%) stop at 75 or younger; 2 take children under 18; 12 take healthy volunteers.

This study: 18 Years to 70 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 21 studies in Dentin Sensitivity by HALEON, or all of them as a file.
02

Study summary

The purpose of this study is to investigate and characterize the Dentine Hypersensitivity (DH) protection profiles of a 0.454 percent (%) Stannous Fluoride (SnF2) toothpaste and a regular fluoride toothpaste, in response to evaporative air (Schiff sensitivity score) and tactile (tactile threshold in grams [g]) stimuli, with twice daily brushing over 2 weeks.

Read the detailed description

This will be a single center, randomized, controlled, examiner-blind, 2-arm, stratified, parallel design clinical study in healthy male and female participants, aged 18-70 years, with self-reported and clinically confirmed DH. Participants who meet the required study criteria at screening and baseline will be randomized to one of two study toothpastes: 0.454% SnF2 toothpaste (Test) or a regular fluoride toothpaste (Negative Control). Sufficient participants will be screened to ensure approximately 80 participants are randomized to study toothpaste (approximately 40 participants per group) and approximately 70 participants complete the study (approximately 35 participants per group).

03

Conditions studied

  • Dentin Sensitivity

Browse trials for

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Provision of signed and dated document confirming the participant has been informed of all pertinent aspects of the study and has given their written consent for study participation before any study procedures are performed.
  • Participant is biologically male or female.
  • Participant is 18 to 70 years of age, inclusive, at the time of signing the consent form.
  • Participant is willing and able to comply with the study visit schedule, toothpaste usage instructions, lifestyle restrictions and other study procedures.
  • Participant is in good general, oral and mental health with, in the opinion of the investigator or medically qualified designee, with no or relevant abnormalities in self-reported medical history, or upon oral examination that would impact their safety or wellbeing, or the outcomes of the study, if they were to participate in the study, or affect their ability to understand and follow study requirements.

Screening (Visit 1)

  • Participants must have:

    1. History of tooth sensitivity lasting more than six months but not more than 10 years (self-reported).
    2. Good general oral health, with a minimum of 20 natural teeth.
    3. Minimum of 2 non-adjacent, accessible teeth (incisors, canines, premolars), in different quadrants, which meet all the following criteria:

      1. Exposed dentine due to facial/cervical erosion or abrasion (that is, tooth wear) or gingival recession (EAR).
      2. Modified Gingival Index (MGI)= 0 directly adjacent to the exposed dentine (that is, the test area only).
      3. Clinical mobility= 0.
      4. Clinically confirmed DH to both tactile and evaporative (air) stimuli: Tactile threshold less than or equal to (\<=) 20g and Schiff sensitivity score more than or equal to (>=) 2.

Baseline (Visit 2)

  • Participant must have a minimum of two non-adjacent, accessible teeth (incisors, canines, premolars), in different quadrants, with clinically confirmed DH to both tactile and evaporative (air) stimuli at both Screening (Visit 1) and Baseline (Visit 2).

    1. Tactile threshold \<= 20g at Screening and Baseline.
    2. Schiff sensitivity score >= 2 at Screening and Baseline.
  • The clinical examiner will select two 'test teeth' from those which meet the tactile threshold and Schiff sensitivity score inclusion criteria at both Screening and Baseline.

Exclusion criteria

Exclusion Criteria:

  • Participant is an employee of the investigator site directly involved in the conduct of the study, or an employee of the investigator site otherwise supervised by the investigator, or a member of their immediate family.
  • Participant is an employee of the sponsor directly involved in the conduct of the study or a member of their immediate family.
  • Female participant who is pregnant or intending to become pregnant during the study (self-reported).
  • Female participant who is breastfeeding (self-reported).
  • Participant with known or suspected intolerance or to the study products, any of their stated ingredients or closely related compounds (self-reported).
  • Participant with a recent history (within the last year) of alcohol or other substance abuse (self-reported).
  • Participant is participating in or has participated in other studies (including non-medicinal studies) involving product(s) within 30 days of Screening (Visit 1) or plans to participate in other studies (including non-medicinal studies) during this study.
  • Participant has participated in a tooth sensitivity study within 8 weeks of Screening (Visit 1).
  • Participant is currently using an oral care product indicated for DH relief or care of sensitive teeth or has used such a product within 8 weeks of Screening (Visit 1).
  • Participant takes daily doses of medications/treatments which, in the opinion of the investigator or medically qualified designee, could interfere with their perception of tooth sensitivity (for example, analgesics, anticonvulsants, antihistamines that cause marked or moderate sedation, sedatives, tranquilizers, antidepressants, mood-altering and anti-inflammatory drugs).
  • Screening (Visit 1): Participant has taken antibiotics in the 2 weeks prior to Screening (Visit 1).
  • Baseline (Visit 2): Participant has taken antibiotics in the 2 weeks prior to Baseline (Visit 2), that is, during the acclimatization period.
  • Participant takes daily doses of a medication which, in the opinion of the investigator or medically qualified designee, is causing xerostomia.
  • Participant requires antibiotic prophylaxis for dental procedures.
  • Participant has had professional tooth de-sensitizing treatment within 8 weeks of Screening (Visit 1).
  • Participant has had a tooth bleaching procedure within 8 weeks of Screening (Visit 1).
  • Participant has had dental prophylaxis within 4 weeks of Screening (Visit 1).
  • Participant has had treatment for periodontal disease (including surgery) within 12 months of Screening (Visit 1).
  • Participant has had scaling or root planning within 3 months of Screening (Visit 1).
  • Participant with gross periodontal disease.
  • Participant with a tongue or lip piercing.
  • Participant with evidence of gross intra-oral neglect or the need for extensive dental therapy.
  • Participant with a fixed or removable partial prosthesis which, in the opinion of the investigator or dentally qualified designee, could impact study outcomes.
  • Participant with multiple dental implants which, in the opinion of the investigator or dentally qualified designee, could impact study outcomes.
  • Participant has had orthodontic treatment (fixed or removable orthodontic braces/bands) within 6 months of Screening (Visit 1).
  • Participant with a fixed or removable orthodontic retainer which, in the opinion of the investigator or dentally qualified designee, could impact study outcomes (for example, participant who is an intermittent user of a removable orthodontic retainer). Note: Teeth involved in a fixed orthodontic retainer may be used as 'test teeth' if, in the opinion of the investigator or dentally qualified designee, their selection would not impact study outcomes.
  • Specific Dentition Exclusions for 'Test teeth':

    1. Tooth with evidence of current/recent dental caries.
    2. Tooth having had (self-reported) treatment for dental caries within 12 months of Screening (Visit 1).
    3. Tooth with exposed dentine and deep, defective, or facial restorations.
    4. Tooth with a full crown or veneer.
    5. Tooth adjacent to a bridge abutment or crown which, in the opinion of the investigator or dentally qualified designee, could impact study outcomes.
    6. Sensitive tooth with contributing etiologies other than EAR to exposed dentine.
    7. Sensitive tooth not expected to benefit from use of a sensitivity toothpaste, in the opinion of the investigator or dentally qualified designee.
  • Participants who, in the opinion of the investigator or designee, are unable to provide appropriate responses to the Labelled Magnitude Scale (LMS) training questions.
  • Participants who, in the opinion of the investigator or medically qualified designee, should not participate in the study.
Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Clinically significant

Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.

Hypersensitivity

An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.

Investigational drug or device

A drug or device being studied in a clinical trial.

It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
85 participants (actual)

Study arms

  • Experimental
    Test Toothpaste

    Participants will dose the toothbrush with a ribbon of test toothpaste, across the full brush head and brush the entire dentition thoroughly for at least 1-timed minute, twice daily (morning and evening) for 2 weeks, making sure to brush the sensitive areas of the two 'test teeth' carefully first.

    Drug: Sensodyne Rapid Relief

  • Active comparator
    Regular Fluoride Toothpaste (Negative Control)

    Participants will dose the toothbrush with a ribbon of regular fluoride toothpaste, across the full brush head and brush the entire dentition thoroughly for at least 1-timed minute, twice daily (morning and evening) for 2 weeks.

    Drug: Colgate Cavity Protection

Interventions

  • DrugSensodyne Rapid Relief

    Toothpaste containing 0.454 % weight/weight (w/w) SnF2 (1100 parts per million \[ppm\] fluoride).

  • DrugFluorophosphateStudies of FluorophosphateFluorophosphate pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.

    A regular fluoride toothpaste containing 1000 ppm fluoride.

06

What researchers measure

Primary outcomes

  1. Least Square (LS) Mean Change From Baseline in Schiff Sensitivity Score at Day 15

    Evaporative (air) sensitivity was assessed by the participant's response to an evaporative (air) stimulus after stimulation of 2 selected test teeth. The participant's response was scored using Schiff Sensitivity Scale, which ranged from 0 to 3, where 0 equal to(=)Did not respond to air stimulation; 1=Responded to air stimulus but did not request discontinuation of stimulus; 2=Responded to air stimulus and requested discontinuation or moved from stimulus and 3=Responded to stimulus, considered stimulus to be painful and requested discontinuation of the stimulus. The Schiff Sensitivity Score was average score of the 2 'test teeth' identified at Baseline. Change from Baseline was calculated as Day 15 score minus Baseline score. A decreased Schiff Sensitivity Score indicated an improvement.

    Time frame: Baseline (Day 1) and Day 15

  2. LS Mean Change From Baseline in Tactile Threshold at Day 15

    The Tactile sensitivity was assessed by administrating a constant pressure using a Yeaple probe. At Baseline, the upper test limit was 20 g(gram) and at Day 15, the upper test limit was 80 g. The Tactile Threshold was defined as the maximum pressure applied without the participant reporting pain or discomfort. The Tactile Threshold for 2 selected test teeth was determined by asking the participant whether the sensation caused discomfort. The pressure setting at which the participant gave two consecutive 'yes' responses was recorded as the Tactile Threshold. The greater the Tactile Threshold, the less sensitive the tooth. The average Tactile Threshold value for the two 'test teeth' identified at Baseline was calculated. Change from Baseline was calculated as Day 15 value minus Baseline value.

    Time frame: Baseline (Day 1) and Day 15

  3. Schiff Sensitivity Score at Baseline, Day 2, Day 8, and Day 15

    Evaporative (air) sensitivity was assessed by participant's response to an evaporative (air) stimulus after stimulation of 2 selected test teeth. The participant's response was scored using Schiff Sensitivity Scale, which ranged from 0 to 3, where 0=Did not respond to air stimulation; 1=Responded to air stimulus but did not request discontinuation of stimulus; 2=Responded to air stimulus and requested discontinuation or moved from stimulus and 3=Responded to stimulus, considered stimulus to be painful and requested discontinuation of the stimulus. The Schiff Sensitivity Score was average score of the 2 'test teeth' identified at Baseline. A decreased Schiff Sensitivity Score indicated an improvement.

    Time frame: Baseline (Day 1), Days 2, 8 and 15

  4. Tactile Threshold at Baseline, Day 2, Day 8, and Day 15

    The Tactile sensitivity was assessed by administrating a constant pressure using a Yeaple probe. At Baseline, the upper test limit was 20 g and at Day 2, 8 and 15, the upper test limit was 80 g. The Tactile Threshold was defined as the maximum pressure applied without the participant reporting pain or discomfort. The Tactile Threshold for 2 selected test teeth was determined by asking the participant whether the sensation caused discomfort. The pressure setting at which the participant gave two consecutive 'yes' responses was recorded as the Tactile Threshold. The greater the Tactile Threshold, the less sensitive the tooth. The average Tactile Threshold value for the two 'test teeth' identified at Baseline was calculated.

    Time frame: Baseline (Day 1), Days 2, 8 and 15

  5. Change From Baseline in Schiff Sensitivity Score at Day 2, Day 8, and Day 15

    Evaporative (air) sensitivity was assessed by participant's response to an evaporative (air) stimulus after stimulation of 2 selected test teeth. The participant's response was scored using Schiff Sensitivity Scale, which ranged from 0 to 3, where 0=Did not respond to air stimulation; 1=Responded to air stimulus but did not request discontinuation of stimulus; 2=Responded to air stimulus and requested discontinuation or moved from stimulus and 3=Responded to stimulus, considered stimulus to be painful and requested discontinuation of the stimulus. The Schiff Sensitivity Score was average score of the 2 'test teeth' identified at Baseline. Change from Baseline was calculated by subtracting Baseline score from the score at the indicated timepoints. A decreased Schiff Sensitivity Score indicated an improvement.

    Time frame: Baseline (Day 1), Days 2, 8 and 15

  6. Change From Baseline in Tactile Threshold at Day 2, Day 8, and Day 15

    The Tactile sensitivity was assessed by administrating a constant pressure using a Yeaple probe. At Baseline, the upper test limit was 20 g and at Day 2, Day 8, and Day 15, the upper test limit was 80 g. The Tactile Threshold was defined as the maximum pressure applied without the participant reporting pain or discomfort. The Tactile Threshold for 2 selected test teeth was determined by asking the participant whether the sensation caused discomfort. The pressure setting at which the participant gave two consecutive 'yes' responses was recorded as the Tactile Threshold. The greater the Tactile Threshold, the less sensitive the tooth. Tactile Threshold= average value for the two 'test teeth' identified at Baseline. Change from Baseline was calculated by subtracting Baseline score from the score at the indicated timepoints.

    Time frame: Baseline (Day 1), Days 2, 8 and 15

Secondary outcomes

  1. LS Mean Change From Baseline in Schiff Sensitivity Score at Day 2 and Day 8

    Evaporative (air) sensitivity was assessed by participant's response to an evaporative (air) stimulus after stimulation of 2 selected test teeth. The participant's response was scored using Schiff Sensitivity Scale, which ranged from 0 to 3, where 0=Did not respond to air stimulation; 1=Responded to air stimulus but did not request discontinuation of stimulus; 2=Responded to air stimulus and requested discontinuation or moved from stimulus and 3=Responded to stimulus, considered stimulus to be painful and requested discontinuation of the stimulus. The Schiff Sensitivity Score was average score of the 2 'test teeth' identified at Baseline. Change from Baseline was calculated by subtracting Baseline score from the score at the indicated timepoints. A decreased Schiff Sensitivity Score indicated an improvement.

    Time frame: Baseline (Day 1), Days 2 and 8

  2. LS Mean Change From Baseline in Tactile Threshold (g) at Day 2 and Day 8

    The Tactile sensitivity was assessed by administrating a constant pressure using a Yeaple probe. At Baseline, the upper test limit was 20 g and at Day 2 and Day 8, the upper test limit was 80 g. The Tactile Threshold was defined as the maximum pressure applied without the participant reporting pain or discomfort. The Tactile Threshold for 2 selected test teeth was determined by asking the participant whether the sensation caused discomfort. The pressure setting at which the participant gave two consecutive 'yes' responses was recorded as the Tactile Threshold. The greater the Tactile Threshold, the less sensitive the tooth. Tactile Threshold= average value for the two 'test teeth' identified at Baseline. Change from Baseline was calculated by subtracting Baseline score from the score at the indicated timepoints.

    Time frame: Baseline (Day 1), Days 2 and 8

  3. LS Mean Change From Baseline in Schiff Sensitivity Score at Day 2, Day 8 and Day 15 (Test Vs Negative Control)

    Evaporative (air) sensitivity was assessed by participant's response to an evaporative (air) stimulus after stimulation of 2 selected test teeth. The participant's response was scored using Schiff Sensitivity Scale, which ranged from 0 to 3, where 0=Did not respond to air stimulation; 1=Responded to air stimulus but did not request discontinuation of stimulus; 2=Responded to air stimulus and requested discontinuation or moved from stimulus and 3=Responded to stimulus, considered stimulus to be painful and requested discontinuation of the stimulus. The Schiff Sensitivity Score was average score of the 2 'test teeth' identified at Baseline. Change from Baseline was calculated by subtracting Baseline score from the score at the indicated timepoints. A decreased Schiff Sensitivity Score indicated an improvement.

    Time frame: Baseline (Day 1), Days 2, 8 and 15

  4. LS Mean Change From Baseline in Tactile Threshold (g) at Day 2, Day 8 and Day 15 (Test Vs Negative Control)

    The Tactile sensitivity was assessed by administrating a constant pressure using a Yeaple probe. At Baseline, the upper test limit was 20 g and at Day 2, Day 8 and Day 15, the upper test limit was 80 g. The Tactile Threshold was defined as the maximum pressure applied without the participant reporting pain or discomfort. The Tactile Threshold for 2 selected test teeth was determined by asking the participant whether the sensation caused discomfort. The pressure setting at which the participant gave two consecutive 'yes' responses was recorded as the Tactile Threshold. The greater the Tactile Threshold, the less sensitive the tooth. Tactile Threshold= average value for the two 'test teeth' identified at Baseline. Change from Baseline was calculated by subtracting Baseline score from the score at the indicated timepoints.

    Time frame: Baseline (Day 1), Days 2, 8 and 15

07

Results

Posted Oct 19, 2026

Participant flow

This study was conducted at a single center in the United Kingdom.

Participant flow — Overall Study
MilestoneTest ToothpasteRegular Fluoride Toothpaste (Negative Control)
Started4241
Completed4041
Not completed20
Withdrew: Participants could not attend week 2 visit within the window period20

Outcome measures

PrimaryLeast Square (LS) Mean Change From Baseline in Schiff Sensitivity Score at Day 15

Evaporative (air) sensitivity was assessed by the participant's response to an evaporative (air) stimulus after stimulation of 2 selected test teeth. The participant's response was scored using Schiff Sensitivity Scale, which ranged from 0 to 3, where 0 equal to(=)Did not respond to air stimulation; 1=Responded to air stimulus but did not request discontinuation of stimulus; 2=Responded to air stimulus and requested discontinuation or moved from stimulus and 3=Responded to stimulus, considered stimulus to be painful and requested discontinuation of the stimulus. The Schiff Sensitivity Score was average score of the 2 'test teeth' identified at Baseline. Change from Baseline was calculated as Day 15 score minus Baseline score. A decreased Schiff Sensitivity Score indicated an improvement.

Time frame:
Baseline (Day 1) and Day 15
Reported as:
Least squares mean · score on a scale
Least Square (LS) Mean Change From Baseline in Schiff Sensitivity Score at Day 15
score on a scaleTest ToothpasteRegular Fluoride Toothpaste (Negative Control)
Least Square (LS) Mean Change From Baseline in Schiff Sensitivity Score at Day 15-1.86 ± 0.091-0.40 ± 0.091
Statistical analysis
  • Test Toothpaste · Mixed Model with Repeated Measures · p = <0.0001
  • Regular Fluoride Toothpaste (Negative Control) · Mixed Model with Repeated Measures · p = <0.0001
PrimaryLS Mean Change From Baseline in Tactile Threshold at Day 15

The Tactile sensitivity was assessed by administrating a constant pressure using a Yeaple probe. At Baseline, the upper test limit was 20 g(gram) and at Day 15, the upper test limit was 80 g. The Tactile Threshold was defined as the maximum pressure applied without the participant reporting pain or discomfort. The Tactile Threshold for 2 selected test teeth was determined by asking the participant whether the sensation caused discomfort. The pressure setting at which the participant gave two consecutive 'yes' responses was recorded as the Tactile Threshold. The greater the Tactile Threshold, the less sensitive the tooth. The average Tactile Threshold value for the two 'test teeth' identified at Baseline was calculated. Change from Baseline was calculated as Day 15 value minus Baseline value.

Time frame:
Baseline (Day 1) and Day 15
Reported as:
Least squares mean · g (grams)
LS Mean Change From Baseline in Tactile Threshold at Day 15
g (grams)Test ToothpasteRegular Fluoride Toothpaste (Negative Control)
LS Mean Change From Baseline in Tactile Threshold at Day 1536.12 ± 2.4855.48 ± 2.525
Statistical analysis
  • Test Toothpaste · Wilcoxon Signed Rank Test · p = <0.0001
  • Regular Fluoride Toothpaste (Negative Control) · Wilcoxon Signed Rank Test · p = 0.0006
PrimarySchiff Sensitivity Score at Baseline, Day 2, Day 8, and Day 15

Evaporative (air) sensitivity was assessed by participant's response to an evaporative (air) stimulus after stimulation of 2 selected test teeth. The participant's response was scored using Schiff Sensitivity Scale, which ranged from 0 to 3, where 0=Did not respond to air stimulation; 1=Responded to air stimulus but did not request discontinuation of stimulus; 2=Responded to air stimulus and requested discontinuation or moved from stimulus and 3=Responded to stimulus, considered stimulus to be painful and requested discontinuation of the stimulus. The Schiff Sensitivity Score was average score of the 2 'test teeth' identified at Baseline. A decreased Schiff Sensitivity Score indicated an improvement.

Time frame:
Baseline (Day 1), Days 2, 8 and 15
Reported as:
Mean · score on a scale
Schiff Sensitivity Score at Baseline, Day 2, Day 8, and Day 15
score on a scaleTest ToothpasteRegular Fluoride Toothpaste (Negative Control)
Baseline2.86 ± 0.3182.89 ± 0.262
Day 22.63 ± 0.4552.76 ± 0.446
Day 81.74 ± 0.7152.49 ± 0.473
Day 151.03 ± 0.6402.49 ± 0.597
PrimaryTactile Threshold at Baseline, Day 2, Day 8, and Day 15

The Tactile sensitivity was assessed by administrating a constant pressure using a Yeaple probe. At Baseline, the upper test limit was 20 g and at Day 2, 8 and 15, the upper test limit was 80 g. The Tactile Threshold was defined as the maximum pressure applied without the participant reporting pain or discomfort. The Tactile Threshold for 2 selected test teeth was determined by asking the participant whether the sensation caused discomfort. The pressure setting at which the participant gave two consecutive 'yes' responses was recorded as the Tactile Threshold. The greater the Tactile Threshold, the less sensitive the tooth. The average Tactile Threshold value for the two 'test teeth' identified at Baseline was calculated.

Time frame:
Baseline (Day 1), Days 2, 8 and 15
Reported as:
Mean · g
Tactile Threshold at Baseline, Day 2, Day 8, and Day 15
gTest ToothpasteRegular Fluoride Toothpaste (Negative Control)
Baseline10.5 ± 1.4910.5 ± 1.87
Day 213.6 ± 7.3411.2 ± 2.71
Day 826.3 ± 15.6712.9 ± 4.06
Day 1544.4 ± 21.2513.7 ± 5.13
PrimaryChange From Baseline in Schiff Sensitivity Score at Day 2, Day 8, and Day 15

Evaporative (air) sensitivity was assessed by participant's response to an evaporative (air) stimulus after stimulation of 2 selected test teeth. The participant's response was scored using Schiff Sensitivity Scale, which ranged from 0 to 3, where 0=Did not respond to air stimulation; 1=Responded to air stimulus but did not request discontinuation of stimulus; 2=Responded to air stimulus and requested discontinuation or moved from stimulus and 3=Responded to stimulus, considered stimulus to be painful and requested discontinuation of the stimulus. The Schiff Sensitivity Score was average score of the 2 'test teeth' identified at Baseline. Change from Baseline was calculated by subtracting Baseline score from the score at the indicated timepoints. A decreased Schiff Sensitivity Score indicated an improvement.

Time frame:
Baseline (Day 1), Days 2, 8 and 15
Reported as:
Mean · score on a scale
Change From Baseline in Schiff Sensitivity Score at Day 2, Day 8, and Day 15
score on a scaleTest ToothpasteRegular Fluoride Toothpaste (Negative Control)
Day 2-0.26 ± 0.322-0.13 ± 0.343
Day 8-1.10 ± 0.620-0.40 ± 0.411
Day 15-1.85 ± 0.643-0.40 ± 0.503
PrimaryChange From Baseline in Tactile Threshold at Day 2, Day 8, and Day 15

The Tactile sensitivity was assessed by administrating a constant pressure using a Yeaple probe. At Baseline, the upper test limit was 20 g and at Day 2, Day 8, and Day 15, the upper test limit was 80 g. The Tactile Threshold was defined as the maximum pressure applied without the participant reporting pain or discomfort. The Tactile Threshold for 2 selected test teeth was determined by asking the participant whether the sensation caused discomfort. The pressure setting at which the participant gave two consecutive 'yes' responses was recorded as the Tactile Threshold. The greater the Tactile Threshold, the less sensitive the tooth. Tactile Threshold= average value for the two 'test teeth' identified at Baseline. Change from Baseline was calculated by subtracting Baseline score from the score at the indicated timepoints.

Time frame:
Baseline (Day 1), Days 2, 8 and 15
Reported as:
Mean · g
Change From Baseline in Tactile Threshold at Day 2, Day 8, and Day 15
gTest ToothpasteRegular Fluoride Toothpaste (Negative Control)
Day 23.1 ± 6.750.7 ± 1.71
Day 815.9 ± 15.512.4 ± 3.92
Day 1533.9 ± 20.773.2 ± 5.45
SecondaryLS Mean Change From Baseline in Schiff Sensitivity Score at Day 2 and Day 8

Evaporative (air) sensitivity was assessed by participant's response to an evaporative (air) stimulus after stimulation of 2 selected test teeth. The participant's response was scored using Schiff Sensitivity Scale, which ranged from 0 to 3, where 0=Did not respond to air stimulation; 1=Responded to air stimulus but did not request discontinuation of stimulus; 2=Responded to air stimulus and requested discontinuation or moved from stimulus and 3=Responded to stimulus, considered stimulus to be painful and requested discontinuation of the stimulus. The Schiff Sensitivity Score was average score of the 2 'test teeth' identified at Baseline. Change from Baseline was calculated by subtracting Baseline score from the score at the indicated timepoints. A decreased Schiff Sensitivity Score indicated an improvement.

Time frame:
Baseline (Day 1), Days 2 and 8
Reported as:
Least squares mean · score on a scale
LS Mean Change From Baseline in Schiff Sensitivity Score at Day 2 and Day 8
score on a scaleTest ToothpasteRegular Fluoride Toothpaste (Negative Control)
Day 2-0.24 ± 0.053-0.12 ± 0.054
Day 8-1.09 ± 0.084-0.39 ± 0.084
Statistical analysis
  • Test Toothpaste · Mixed Model with Repeated Measures · p = <0.0001
  • Regular Fluoride Toothpaste (Negative Control) · Mixed Model with Repeated Measures · p = 0.0247
  • Test Toothpaste · Mixed Model with Repeated Measures · p = <0.0001
  • Regular Fluoride Toothpaste (Negative Control) · Mixed Model with Repeated Measures · p = <0.0001
SecondaryLS Mean Change From Baseline in Tactile Threshold (g) at Day 2 and Day 8

The Tactile sensitivity was assessed by administrating a constant pressure using a Yeaple probe. At Baseline, the upper test limit was 20 g and at Day 2 and Day 8, the upper test limit was 80 g. The Tactile Threshold was defined as the maximum pressure applied without the participant reporting pain or discomfort. The Tactile Threshold for 2 selected test teeth was determined by asking the participant whether the sensation caused discomfort. The pressure setting at which the participant gave two consecutive 'yes' responses was recorded as the Tactile Threshold. The greater the Tactile Threshold, the less sensitive the tooth. Tactile Threshold= average value for the two 'test teeth' identified at Baseline. Change from Baseline was calculated by subtracting Baseline score from the score at the indicated timepoints.

Time frame:
Baseline (Day 1), Days 2 and 8
Reported as:
Least squares mean · g
LS Mean Change From Baseline in Tactile Threshold (g) at Day 2 and Day 8
gTest ToothpasteRegular Fluoride Toothpaste (Negative Control)
Day 25.19 ± 1.1892.97 ± 1.241
Day 818.23 ± 1.9534.70 ± 1.993
Statistical analysis
  • Test Toothpaste · Wilcoxon Signed Rank Test · p = 0.0010
  • Regular Fluoride Toothpaste (Negative Control) · Wilcoxon Signed Rank Test · p = 0.0625
  • Test Toothpaste · Wilcoxon Signed Rank Test · p = <0.0001
  • Regular Fluoride Toothpaste (Negative Control) · Wilcoxon Signed Rank Test · p = 0.0004
SecondaryLS Mean Change From Baseline in Schiff Sensitivity Score at Day 2, Day 8 and Day 15 (Test Vs Negative Control)

Evaporative (air) sensitivity was assessed by participant's response to an evaporative (air) stimulus after stimulation of 2 selected test teeth. The participant's response was scored using Schiff Sensitivity Scale, which ranged from 0 to 3, where 0=Did not respond to air stimulation; 1=Responded to air stimulus but did not request discontinuation of stimulus; 2=Responded to air stimulus and requested discontinuation or moved from stimulus and 3=Responded to stimulus, considered stimulus to be painful and requested discontinuation of the stimulus. The Schiff Sensitivity Score was average score of the 2 'test teeth' identified at Baseline. Change from Baseline was calculated by subtracting Baseline score from the score at the indicated timepoints. A decreased Schiff Sensitivity Score indicated an improvement.

Time frame:
Baseline (Day 1), Days 2, 8 and 15
Reported as:
Least squares mean · score on a scale
LS Mean Change From Baseline in Schiff Sensitivity Score at Day 2, Day 8 and Day 15 (Test Vs Negative Control)
score on a scaleTest ToothpasteRegular Fluoride Toothpaste (Negative Control)
Day 2-0.24 ± 0.053-0.12 ± 0.054
Day 8-1.09 ± 0.084-0.39 ± 0.084
Day 15-1.86 ± 0.091-0.40 ± 0.091
Statistical analysis
  • Test Toothpaste vs Regular Fluoride Toothpaste (Negative Control) · Mixed Model with Repeated Measures · p = 0.1378 · Adjusted mean difference: -0.11 · 95% CI -0.26 to 0.04
  • Test Toothpaste vs Regular Fluoride Toothpaste (Negative Control) · Mixed Model with Repeated Measures · p = <0.0001 · Adjusted mean difference: -0.69 · 95% CI -0.93 to -0.46
  • Test Toothpaste vs Regular Fluoride Toothpaste (Negative Control) · Mixed Model with Repeated Measures · p = <0.0001 · Adjusted mean difference: -1.46 · 95% CI -1.71 to -1.20
SecondaryLS Mean Change From Baseline in Tactile Threshold (g) at Day 2, Day 8 and Day 15 (Test Vs Negative Control)

The Tactile sensitivity was assessed by administrating a constant pressure using a Yeaple probe. At Baseline, the upper test limit was 20 g and at Day 2, Day 8 and Day 15, the upper test limit was 80 g. The Tactile Threshold was defined as the maximum pressure applied without the participant reporting pain or discomfort. The Tactile Threshold for 2 selected test teeth was determined by asking the participant whether the sensation caused discomfort. The pressure setting at which the participant gave two consecutive 'yes' responses was recorded as the Tactile Threshold. The greater the Tactile Threshold, the less sensitive the tooth. Tactile Threshold= average value for the two 'test teeth' identified at Baseline. Change from Baseline was calculated by subtracting Baseline score from the score at the indicated timepoints.

Time frame:
Baseline (Day 1), Days 2, 8 and 15
Reported as:
Least squares mean · g
LS Mean Change From Baseline in Tactile Threshold (g) at Day 2, Day 8 and Day 15 (Test Vs Negative Control)
gTest ToothpasteRegular Fluoride Toothpaste (Negative Control)
Day 25.19 ± 1.1892.97 ± 1.241
Day 818.23 ± 1.9534.70 ± 1.993
Day 1536.12 ± 2.4855.48 ± 2.525
Statistical analysis
  • Test Toothpaste vs Regular Fluoride Toothpaste (Negative Control) · Van Elteren Test · p = 0.0849 (Method used for estimates and P-values was MMRM. Where MMRM assumptions are violated, a supportive non-parametric P-value was used (Van Elteren Test) and presented here.) · Adjusted mean difference: 2.22 · 95% CI 0.05 to 4.39
  • Test Toothpaste vs Regular Fluoride Toothpaste (Negative Control) · Van Elteren Test · p = <0.0001 (Method used for estimates and P-values was MMRM. Where MMRM assumptions are violated, a supportive non-parametric P-value was used (Van Elteren Test) and presented here.) · Adjusted mean difference: 13.52 · 95% CI 8.61 to 18.44
  • Test Toothpaste vs Regular Fluoride Toothpaste (Negative Control) · Van Elteren Test · p = <0.0001 (Method used for estimates and P-values was MMRM. Where MMRM assumptions are violated, a supportive non-parametric P-value was used (Van Elteren Test) and presented here.) · Adjusted mean difference: 30.64 · 95% CI 24.08 to 37.21

Adverse events

Collected over Immediately after a participant provided consent to participate in the study by the completion (signature) of the Informed consent form (ICF) and until 5 days following the last administration of study product (or the last study procedure) (Approximately up to 34 days).. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Test Toothpaste0/42 (0%)0/42 (0%)5/42 (11.9%)
Regular Fluoride Toothpaste (Negative Control)0/41 (0%)0/41 (0%)3/41 (7.3%)
Most frequent other events
Most frequent other events
EventTest ToothpasteRegular Fluoride Toothpaste (Negative Control)
Burn oral cavityInjury, poisoning and procedural complications0/422/41
HeadacheNervous system disorders2/420/41
Oral herpesInfections and infestations0/421/41
Gingival injuryInjury, poisoning and procedural complications1/420/41
Mouth injuryInjury, poisoning and procedural complications1/420/41
Skin bacterial infectionInfections and infestations1/420/41

Baseline characteristics

The Safety population included all randomised participants who completed at least one use of study toothpaste.

Age, Continuous
Age, Continuous(years)Test ToothpasteRegular Fluoride Toothpaste (Negative Control)Total
Mean41.4 ± 11.4542.0 ± 13.3741.7 ± 12.36
Sex: Female, Male
Sex: Female, Male(Participants)Test ToothpasteRegular Fluoride Toothpaste (Negative Control)Total
Female323062
Male101121
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Test ToothpasteRegular Fluoride Toothpaste (Negative Control)Total
Hispanic or Latino022
Not Hispanic or Latino423981
Unknown or Not Reported000
Race/Ethnicity, Customized
Race/Ethnicity, Customized(Participants)Test ToothpasteRegular Fluoride Toothpaste (Negative Control)Total
African American/African Heritage6511
Asian - Central/South Asian Heritage336
Asian - East Asian Heritage7310
Asian - South East Asian Heritage011
White - White/Caucasian/European Heritage262753
Multiple022
08

Study locations

1 site
  • University of Bristol, Bristol Dental School and Hospital
    Bristol, BS1 2LY, United Kingdom
09

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Yes — Anonymized individual participant data and study documents can be requested for further research from ww.clinical-trial-register@haleon.com.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: IPD will be made available within 6 months of publishing the results of the primary endpoints, key secondary endpoints and safety data of the study.

Access criteria: Access is provided after a research proposal is submitted and has received approval from the Independent Review Panel and after a Data Sharing Agreement is in place. Access is provided for an initial period of 12 months, but an extension can be granted, when justified, for up to another 12 months.

10

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Feb 2025 to primary completion in May 2025, 3 months.

Results were first posted in Oct 2026, 1 year 4 months after primary completion.

Of 34 industry-sponsored interventional studies with no phase under Dentin Sensitivity, half reached primary completion within 3 months of starting (the median), counting those still running; a quarter within 2 and three quarters within 6. This study's 3 months is close to that.

Counting every sponsor, half of 146 studies reached it within 6 months; a quarter within 3 and three quarters within 10.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 10, 2024
First posted
Dec 13, 2024
StartActual
Feb 4, 2025
Primary completionActual
May 27, 2025
CompletionActual
May 27, 2025
Results first posted
Oct 19, 2026
Last update
Oct 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Results
Results posted
posted Oct 19, 2026
Primary outcomes
2 edited, 4 description edited
What changed in the outcomes
  • EditedLeast Square (LS) Mean Change fromFrom Baseline in Schiff Sensitivity Score at Day 15Time frame: Baseline (Day 1) and Day 15
  • EditedLS Mean Change fromFrom Baseline in Tactile Threshold at Day 15Time frame: Baseline (Day 1) and Day 15
  • DescriptionChange From Baseline in Schiff Sensitivity Score at Day 2, Day 8, and Day 15: how it is measured was reworded
  • DescriptionChange From Baseline in Tactile Threshold at Day 2, Day 8, and Day 15: how it is measured was reworded
  • DescriptionSchiff Sensitivity Score at Baseline, Day 2, Day 8, and Day 15: how it is measured was reworded
  • DescriptionTactile Threshold at Baseline, Day 2, Day 8, and Day 15: how it is measured was reworded
Oct 19, 2026
Documents
Secondary outcomes
4 edited
What changed in the outcomes
  • EditedLS Mean Change fromFrom Baseline in Schiff Sensitivity Score at Day 2 and Day 8Time frame: Baseline (Day 1), Days 2 and 8
  • EditedLS Mean Change fromFrom Baseline in Tactile Threshold (g) at Day 2 and Day 8Time frame: Baseline (Day 1), Days 2 and 8
  • EditedLS Mean Change fromFrom Baseline in Schiff Sensitivity Score at Day 2, Day 8 and Day 15 (Test Versus [Vs] Negative Control)Time frame: Baseline (Day 1), Days 2, 8 and 15
  • EditedLS Mean Change fromFrom Baseline in Tactile Threshold (g) at Day 2, Day 8 and Day 15 (Test Vs Negative Control)Time frame: Baseline (Day 1), Days 2, 8 and 15
Oct 19, 2026
Show all 1 update
  1. Oct 19, 2026
    Results posted
    Primary outcomes 2 edited, 4 description edited
    What changed in the outcomes
    • EditedLeast Square (LS) Mean Change fromFrom Baseline in Schiff Sensitivity Score at Day 15Time frame: Baseline (Day 1) and Day 15
    • EditedLS Mean Change fromFrom Baseline in Tactile Threshold at Day 15Time frame: Baseline (Day 1) and Day 15
    • DescriptionChange From Baseline in Schiff Sensitivity Score at Day 2, Day 8, and Day 15: how it is measured was reworded
    • DescriptionChange From Baseline in Tactile Threshold at Day 2, Day 8, and Day 15: how it is measured was reworded
    • DescriptionSchiff Sensitivity Score at Baseline, Day 2, Day 8, and Day 15: how it is measured was reworded
    • DescriptionTactile Threshold at Baseline, Day 2, Day 8, and Day 15: how it is measured was reworded
    Secondary outcomes 4 edited
    What changed in the outcomes
    • EditedLS Mean Change fromFrom Baseline in Schiff Sensitivity Score at Day 2 and Day 8Time frame: Baseline (Day 1), Days 2 and 8
    • EditedLS Mean Change fromFrom Baseline in Tactile Threshold (g) at Day 2 and Day 8Time frame: Baseline (Day 1), Days 2 and 8
    • EditedLS Mean Change fromFrom Baseline in Schiff Sensitivity Score at Day 2, Day 8 and Day 15 (Test Versus [Vs] Negative Control)Time frame: Baseline (Day 1), Days 2, 8 and 15
    • EditedLS Mean Change fromFrom Baseline in Tactile Threshold (g) at Day 2, Day 8 and Day 15 (Test Vs Negative Control)Time frame: Baseline (Day 1), Days 2, 8 and 15
    + 2 other changes: index terms and verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

11

Registry details

Key details

Study ID
NCT06733285
Lead sponsor
HALEON
Responsible party
Sponsor
First posted
Dec 13, 2024
Start date
Feb 4, 2025
Primary completion
May 27, 2025
Completion
May 27, 2025
Results posted
Oct 19, 2026
Last update
Oct 19, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion